The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma. - Wikidata - wikimedia - TriplyDB

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

http://www.wikidata.org/entity/Q34724977

about

Risk factors for neoplastic progression in Barrett's esophagus Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junction A review of the past, present, and future directions of neoplasia Neoplasia: Where We Have Been and Where We Are Going Absolute quantitation of Met using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue.c-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancer MALDI imaging on large-scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancer.Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.A local effect of CYP24 inhibition on lung tumor xenograft exposure to 1,25-dihydroxyvitamin D(3) is revealed using a novel LC-MS/MS assay Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma.Expression of HGF and Met in human tissues of colorectal cancers: biological and clinical implications for synchronous liver metastasis Nicotine Reduces Survival via Augmentation of Paracrine HGF-MET Signaling in the Pancreatic Cancer Microenvironment Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.Forthcoming prognostic markers for esophageal cancer: a systematic review and meta-analysis.Barrett's Esophagus: A Review of Biology and Therapeutic Approaches.Ad-IRF-1 induces apoptosis in esophageal adenocarcinoma.In silico dissection of miRNA targetome polymorphisms and their role in regulating miRNA-mediated gene expression in esophageal cancer.EGFR family and cMet expression profiles and prognostic significance in esophagogastric adenocarcinoma.Chemopreventive effects of tolfenamic acid against esophageal tumorigenesis in rats.Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma.Prognostic Value of C-met Expression in Cholangiocarcinoma.Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?TGFβ1 and HGF protein secretion by esophageal squamous epithelial cells and stromal fibroblasts in oesophageal carcinogenesis.Neoplasia: An Anniversary of Progress.A Phase 1 study evaluating AMG 337 in Asian patients with advanced solid tumors.Role of HGF-MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer.

P2860

Q27002062-0700FF47-190D-4115-A279-2F9615A355E9 Q27026253-1AE1075D-FC96-477F-9DB1-AC047C1981DD Q28389391-1E9BD402-CEDA-4A1B-8FCF-527DCAAFE599 Q28395095-9666C252-A828-4A71-AF81-D5AA65D1C303 Q33830522-E3911097-A1B2-4C25-B6DB-F695F683AF7D Q33886974-A4618D1F-D2DA-47D4-B4CE-B61C1E9363FA Q34820809-A6E355EE-CF0A-4A72-9F1E-CEAE7B21EDE0 Q35108386-496220EF-BFC6-42C1-8B5B-733AB35B1DDF Q35146597-B989219E-CBF1-45AB-9BF6-93A52055B477 Q35666332-3BD9D432-0EA5-4D93-9FB1-AF75D477A366 Q35830723-A1E122EE-1064-413E-B477-5C3BD680158F Q36205151-396F82A4-7CAC-4FC4-8B34-4568E8BC53C7 Q36510119-49BFD4E7-CA8D-4306-A7D5-6C74489AC40F Q36713414-F9146D82-78C6-44A9-AC70-97768C99E612 Q36759077-11F9B8FF-7801-4997-A42B-DAAEE260CAA2 Q37246675-B378F815-2118-43C7-84D0-9A582366F1C4 Q37522222-3E2DC443-C71E-4C9D-8C1D-2ACD0DB5D6F2 Q38018063-C09E50EF-3071-436B-9E5B-940D409B0323 Q38273489-5AB88255-6A52-456C-B756-3D161E09B82D Q38831897-2C051BC6-600F-47B0-82EA-FB24F7715C03 Q39025928-36A6F3FE-F68D-429E-9EC9-301B8CB74291 Q39613072-0078AB3E-0ED6-49E7-969C-BA3538C6EB94 Q40203442-C5688F02-9687-4AFF-8F58-A3896CC6712B Q41073453-C3E7AA86-AE98-44A7-B838-06C46B72FBAB Q41231601-EBA39F7E-DF0D-42C8-A925-A1CE677E8B91 Q41832195-B4E40055-2A38-4489-AB60-9FAFF6CCA023 Q46932476-0173DB38-B9CE-4D68-95CF-6E7688964DD5 Q50958892-F8D801FD-CAA1-4E11-A4B6-328E50B2F000 Q53711253-DB30BDE8-0AE7-4809-B139-80EDD8730D85

P2860

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

http://www.wikidata.org/entity/Q34724977

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

@ast

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

@en

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

@nl

type

label

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

@ast

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

@en

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

@nl

prefLabel

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

@ast

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

@en

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.

@nl

P1433

Q34724977-8A792CD2-0D5D-47D9-9113-C1F61609CBD6

P1476

Q34724977-13F8C190-399F-46AE-A14E-1E579F5997EC

P2093

Q34724977-02F6E0A9-0D24-494F-9B2A-B079F3ADAC9E

Q34724977-263F680F-EBAC-4366-BE7D-5D889D446BE4

Q34724977-3DB4B66E-309A-4102-BD19-43565026996B

Q34724977-54205058-CF32-45D3-B2A4-D5441998BEF4

Q34724977-A2444598-3E94-4F8A-B349-EC68CA527923

Q34724977-A65B272E-7874-4D2E-B182-FC9F8808021E

Q34724977-ACFB855C-D807-45E6-8E34-2D9522C86973

Q34724977-D9F24B23-E9B6-4247-B1F5-030AF5C99D2C

P2860

Q34724977-04F28690-52DD-42D8-B476-9C2484222E40

Q34724977-0D510B74-8253-4474-87CC-16E31495BA2F

Q34724977-188599D1-1C3D-43FF-8AD5-7556937A3B95

Q34724977-201F403B-0025-4BB6-83C9-AC577F4F9CE8

Q34724977-205A6568-5E7A-4A03-9D3C-17ED64B28208

Q34724977-41F59C7C-3395-4D97-9B1B-6132DAA68D46

Q34724977-5324B537-5036-4EB7-A4F4-2ED9245FFD1D

Q34724977-6DBDF445-C06D-4703-93E2-39A2C5D4E1D3

Q34724977-716A7F64-C79E-4750-B5F3-86838B097D03

Q34724977-8A922F34-CEE3-4F70-93B8-A8DAC8A78283

P304

Q34724977-ECF800CA-3FA8-4CB7-9B76-1569E6C3AFA1

P31

Q34724977-FC353326-C5CF-4B16-8BBD-BD339535CF57

P356

Q34724977-25265F41-06C7-46BD-8815-CD4515B2AD0D

P433

Q34724977-78DCCD57-151A-4957-94C7-E7AB6D20D508

P478

Q34724977-0E7F6C77-8B3A-4114-AB1E-E35CD720DF3A

P50

Q34724977-DF10B724-6E64-4BFF-950F-FF40A6E23864

P577

Q34724977-2EE2EE6A-D33F-49F2-B5AC-BDF4586643FB

P5875

Q34724977-299F88E9-58F0-4F42-9BC6-DA74F09DE4A9

P698

Q34724977-0873C205-DCB6-4BE9-89C4-0600E3CCF547

P921

Q34724977-597CC952-5FDB-455E-9B11-F9200F1A9076

Q34724977-ABA70309-D6F2-4CD9-9BF8-CAF50CDF501B

P932

Q34724977-8FA24C74-F567-4901-9300-75C2E6347328

P356

P1433

P1476

The HGF receptor c-Met is overexpressed in esophageal adenocarcinoma

@en

P2093

James D Luketich

http://www.w3.org/2001/XMLSchema#string

Luis J Herrera

http://www.w3.org/2001/XMLSchema#string

Pierre E Queiroz de Oliveira

http://www.w3.org/2001/XMLSchema#string

Siva Raja

http://www.w3.org/2001/XMLSchema#string

Steven J Hughes

http://www.w3.org/2001/XMLSchema#string

Sydney Finkelstein

http://www.w3.org/2001/XMLSchema#string

Talal El-Hefnawy

http://www.w3.org/2001/XMLSchema#string

William Gooding

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product

Met receptor tyrosine kinase: enhanced signaling through adapter proteins

Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence

Cancer statistics, 2001

Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.

A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase.

Selective cyclooxygenase-2 blocker delays healing of esophageal ulcers in rats and inhibits ulceration-triggered c-Met/hepatocyte growth factor receptor induction and extracellular signal-regulated kinase 2 activation.

Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells.

Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network

Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor

P304

75-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/NEO.04367

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8012252

http://www.w3.org/2001/XMLSchema#string

P698

15720819

http://www.w3.org/2001/XMLSchema#string

P921

P932

1490312

http://www.w3.org/2001/XMLSchema#string